Abstract
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that is associated with significant morbidity and mortality, giving rise to an enormous social and economic burden. The Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) report is one of the most frequently used documents for managing COPD patients worldwide. A survey was conducted across country-level members of Asia-Pacific Society of Respiratory (APSR) for collecting an updated version of local COPD guidelines, which were implemented in each country. This is the first report to summarize the similarities and differences among the COPD guidelines across the Asia-Pacific region. The degree of airflow limitation, assessment of COPD severity, management, and pharmacologic therapy of stable COPD will be reviewed in this report.
Highlights
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease, it is associated with significant morbidity and mortality, giving rise to an enormous social and economic burden
A survey was conducted across country-level members of the Asia-Pacific Society of Respiratory (APSR) for collecting an updated version of chronic obstructive pulmonary disease (COPD) guidelines which were implemented in each country
The degree of airflow limitation, assessment of COPD severity, management, and pharmacologic therapy of stable COPD were based on the GOLD principles
Summary
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease, it is associated with significant morbidity and mortality, giving rise to an enormous social and economic burden. Individuals with the disease reported substantial limitations in their daily activities and loss in work productivity To address this situation and influence the behavior of healthcare providers and health policy makers and payers, numerous organizations have developed clinical practice guidelines (CPG) to assist in the diagnosis and treatment of COPD. In such an environment, CPG development often relies upon expert opinion. Conflicting interpretations of the literature regarding COPD management may result in disparities across guidelines Local factors, such as the availability of certain health care services or the cost impact of an intervention, may influence how local experts view and apply the published literature during guideline development
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
